IGM Biosciences, Inc. Contracts & Agreements
52 Contracts & Agreements
- Business Finance (18 contracts)
- Business Operations (2)
- Human Resources (25)
- Real Estate (2)
- Uncategorized (5)
- Consulting Agreement, by and between the Registrant and William Strohl, Ph.D., dated August 8, 2024 (Filed With SEC on November 8, 2024)
- Transition and Consulting Agreement, by and between the Registrant and Bruce Keyt, dated October 1, 2024 (Filed With SEC on November 8, 2024)
- Employment Agreement, by and between the Registrant and Mary Beth Harler, M.D., dated September 30, 2024 (Filed With SEC on November 8, 2024)
- Transition and Consulting Agreement, by and between the Registrant and Fred Schwarzer, dated September 30, 2024 (Filed With SEC on November 8, 2024)
- Outside Director Compensation Policy (as amended and restated on February 26, 2024) (Filed With SEC on March 7, 2024)
- Amended and Restated 2019 Employee Stock Purchase Plan, amended October 30, 2023, and forms of agreements thereunder (Filed With SEC on March 7, 2024)
- Amended and Restated 2019 Employee Stock Purchase Plan, amended October 30, 2023, and forms of agreements thereunder (Filed With SEC on November 13, 2023)
- IGM Biosciences, Inc. Amended and Restated Change in Control and Severance Policy (Filed With SEC on August 3, 2023)
- IGM Biosciences, Inc. Amended and Restated 2018 Omnibus Incentive Plan (Filed With SEC on June 27, 2023)
- Common Stock Purchase Agreement, dated as of June 22, 2023, between IGM Biosciences, Inc. and RedCo II Master Fund, L.P (Filed With SEC on June 23, 2023)
- Underwriting Agreement, dated as of June 22, 2023, among IGM Biosciences, Inc. and the Representatives (Filed With SEC on June 23, 2023)
- Amended and Restated 2019 Employee Stock Purchase Plan, amended May 1, 2022, and forms of agreements thereunder (Filed With SEC on May 9, 2022)
- Underwriting Agreement, dated as of March 29, 2022, among IGM Biosciences, Inc. and the Representatives (Filed With SEC on March 30, 2022)
- Collaboration and License Agreement by and between IGM Biosciences, Inc. and Genzyme Corporation, dated March 28, 2022 (Filed With SEC on March 29, 2022)
- Outside Director Compensation Policy (as amended and restated on February 7, 2022) (Filed With SEC on March 29, 2022)
- Description of Securities (Filed With SEC on March 29, 2022)
- Outside Director Compensation Policy (as amended and restated on September 24, 2021) (Filed With SEC on November 4, 2021)
- Employment Agreement by and between Chris Takimoto and the Registrant, dated as of July 29, 2021 (Filed With SEC on August 9, 2021)
- First Amendment to Lease between IGM Biosciences, Inc. and Real Property Investments, LLC effective July 1, 2021 (Filed With SEC on July 13, 2021)
- Employment Agreement by and between George Gauthier and the Registrant, dated as of February 10, 2021 (Filed With SEC on May 6, 2021)
- Employment Agreement by and between Lisa Decker and the Registrant, dated as of February 25, 2021 (Filed With SEC on May 6, 2021)
- Outside Director Compensation Policy (as amended and restated on February 19, 2021) (Filed With SEC on March 30, 2021)
- Description of Securities (Filed With SEC on March 30, 2021)
- Form of Pre-Funded Warrant (Filed With SEC on December 9, 2020)
- Underwriting Agreement, dated as of December 8, 2020, by and among the Company and the Representatives (Filed With SEC on December 9, 2020)
- Form of Registration Rights Agreement, by and between the Registrant and certain securityholders (Filed With SEC on December 7, 2020)
- Amended and Restated 2018 Omnibus Incentive Plan, amended July 30, 2020 and forms of agreements thereunder (Filed With SEC on November 5, 2020)
- Amended and Restated 2019 Employee Stock Purchase Plan, amended July 30, 2020 and forms of agreements thereunder (Filed With SEC on November 5, 2020)
- Amended and Restated 2018 Omnibus Incentive Plan (Filed With SEC on August 3, 2020)
- Amended and Restated 2019 Employee Stock Purchase Plan (Filed With SEC on August 3, 2020)
- Outside Director Compensation Policy (as amended and restated on February 5, 2020) (Filed With SEC on March 26, 2020)
- Description of Securities (Filed With SEC on March 26, 2020)
- Specimen common stock certificate of the Registrant (Filed With SEC on September 3, 2019)
- Form of Underwriting Agreement (Filed With SEC on September 3, 2019)
- 2018 Omnibus Incentive Plan and forms of agreements thereunder (Filed With SEC on September 3, 2019)
- Amended and Restated 2018 Omnibus Incentive Plan and forms of agreements thereunder, to be in effect upon completion of this offering (Filed With SEC on September 3, 2019)
- 2019 Employee Stock Purchase Plan and forms of agreements thereunder, to be in effect upon completion of this offering (Filed With SEC on September 3, 2019)
- Form of Indemnification Agreement, by and between the Registrant and each of its directors and executive officers (Filed With SEC on September 3, 2019)
- Outside Director Compensation Policy (Filed With SEC on September 3, 2019)
- Confirmatory Employment Letter, by and between Misbah Tahir and the Registrant, effective as of August 19, 2019 (Filed With SEC on August 19, 2019)
- Confirmatory Employment Letter, by and between Bruce Keyt and the Registrant, effective as of August 19, 2019 (Filed With SEC on August 19, 2019)
- Restricted Stock Grant Agreement, by and between Daniel Chen and the Registrant, dated as of December 30, 2018 (Filed With SEC on August 19, 2019)
- Employment Agreement, by and between Daniel Chen and the Registrant, dated as of July 12, 2018 (Filed With SEC on August 19, 2019)
- Confirmatory Employment Letter, by and between Fred Schwarzer and the Registrant, effective as of August 19, 2019 (Filed With SEC on August 19, 2019)
- Amended and Restated 2010 Stock Plan and forms of agreement thereunder (Filed With SEC on August 19, 2019)
- Amended and Restated Investor Rights Agreement, by and among the Registrant and certain of its stockholders, dated as of June 28, 2019 (Filed With SEC on August 19, 2019)
- Change in Control and Severance Policy (Filed With SEC on August 19, 2019)
- Executive Incentive Compensation Plan (Filed With SEC on August 19, 2019)
- Lease by and between Real Property Investments, LLC and the Registrant, dated February 27, 2019 (Filed With SEC on August 19, 2019)
- Nominating Agreement, by and among 667, L.P., Baker Brothers Life Sciences, L.P. and the Registrant, dated as of June 28, 2019 (Filed With SEC on August 19, 2019)
- Nominating Agreement, by and between Haldor Topse Holding A/S and the Registrant, dated as of June 28, 2019 (Filed With SEC on August 19, 2019)
- Nominating Agreement, by and among Redmile Biopharma Investments II, L.P., RAF, L.P., Redmile Strategic Master Fund, LP and the Registrant, dated as of June 28, 2019 (Filed With SEC on August 19, 2019)
